SCHEMBL28313231

SCHEMBL28313231

CCC(Cc1ccc(F)cc1)C(N)=O

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.50
PPARG P37231 2/20 0.50
TDP1 Q9NUW8 2/20 0.46
TRPA1 O75762 1/20 0.44
EPHX1 P07099 2/20 0.42
PPARD Q03181 1/20 0.42
PPARA Q07869 1/20 0.42
CYP1A2 P05177 1/20 0.41
GAA P10253 1/20 0.41
MAPK1 P28482 1/20 0.41
CPA1 P15085 1/20 0.41
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
POLB P06746 1/20 0.40
APEX1 P27695 1/20 0.40
MMP2 P08253 1/20 0.40
MMP9 P14780 1/20 0.40
MMP12 P39900 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7772237 0.89 EPHX1 (0.46) TRPA1EPHX1CYP1A2CPA1MMP2
SCHEMBL5378074 0.84 CYP1A2 (0.57) EPHX2PPARGTDP1PPARDPPARA
SCHEMBL12118655 0.84 EPHX1 (0.43) EPHX2PPARGEPHX1PPARDPPARA
SCHEMBL1825965 0.81 CYP1A2 (0.64) EPHX2PPARGTRPA1EPHX1CYP1A2
SCHEMBL7333189 0.81 PPARG (0.49) EPHX2PPARGTDP1TRPA1PPARD
SCHEMBL15933205 0.79 EPHX2 (0.73) EPHX2PPARGTDP1PPARACYP1A2
SCHEMBL22240364 0.79 EPHX2 (0.73) EPHX2PPARGTDP1PPARACYP1A2
SCHEMBL7384829 0.79 CYP1A2 (0.65) PPARGPPARACYP1A2CPA1MMP2
SCHEMBL5720704 0.79 CYP1A2 (0.41) EPHX1CYP1A2GAAMAPK1CA1
SCHEMBL13575658 0.78 PPARG (0.56) EPHX2PPARGTDP1PPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105873915-B For treating the compound of mental illness BRISTOL-MYERS SQUIBB CO. (US) 2019-07-16 CN disclosed